Mesa Laboratories Inc. (MLAB)
NASDAQ: MLAB
· Real-Time Price · USD
64.75
0.42 (0.65%)
At close: Sep 05, 2025, 3:59 PM
63.34
-2.18%
After-hours: Sep 05, 2025, 07:54 PM EDT
Mesa Laboratories Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Dec 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|
| Biopharmaceutical Development Revenue | 11.49M | 12.19M | 9.43M | 9.21M | 9.89M | 10.1M | 8.71M | 9.13M | 5.95M | 5.64M |
| Biopharmaceutical Development Revenue Growth | -5.74% | +29.23% | +2.42% | -6.90% | -2.10% | +15.96% | -4.60% | +53.49% | +5.53% | n/a |
| Calibration Solutions Revenue | 12.35M | 12.81M | 12.16M | 11.33M | 11.46M | 15.42M | 13.08M | 11.55M | n/a | n/a |
| Calibration Solutions Revenue Growth | -3.63% | +5.40% | +7.33% | -1.14% | -25.70% | +17.94% | +13.20% | n/a | n/a | n/a |
| Clinical Genomics Revenue | 10.3M | 11.12M | 12.55M | 15.55M | 13.37M | n/a | n/a | n/a | n/a | n/a |
| Clinical Genomics Revenue Growth | -7.43% | -11.33% | -19.31% | +16.31% | n/a | n/a | n/a | n/a | n/a | n/a |
| Sterilization and Disinfection Control Revenue | 25.41M | 22.78M | 19.34M | 17.08M | 15.93M | n/a | n/a | n/a | n/a | n/a |
| Sterilization and Disinfection Control Revenue Growth | +11.55% | +17.79% | +13.22% | +7.24% | n/a | n/a | n/a | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 | Mar 31, 2014 | Dec 31, 2013 | Sep 30, 2013 | Sep 30, 2012 | Jun 30, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China Revenue | 5.43M | 5.04M | 6.32M | 7.39M | 6.56M | 6.35M | 4.94M | 7.53M | 6.11M | 10.84M | 7.48M | 7.48M | 29.12M | 30.82M | 30.41M | 19.38M | 18.45M | 19.14M | 18.48M | 11.22M | 16.37M | 18.34M | 17.81M | 15.01M | 15.19M | 17M | 16.62M | 15.55M | 14.22M | 14.43M | 13.01M | 8.23M | 13.84M | 15.4M | 15.51M | 15.58M | 12.79M | 12.53M | 12.19M | 16.19M | 11.42M | 9.7M | 8.49M | 8.67M | 7.05M | 7.79M | 7.12M | 6.37M |
| China Revenue Growth | +7.70% | -20.26% | -14.45% | +12.67% | +3.31% | +28.47% | -34.36% | +23.16% | -43.58% | +44.81% | +0.03% | -74.31% | -5.49% | +1.32% | +56.90% | +5.03% | -3.58% | +3.58% | +64.68% | -31.46% | -10.72% | +2.96% | +18.69% | -1.22% | -10.66% | +2.32% | +6.88% | +9.33% | -1.46% | +10.92% | +58.07% | -40.54% | -10.12% | -0.70% | -0.47% | +21.87% | +2.06% | +2.75% | -24.66% | +41.70% | +17.79% | +14.22% | -2.11% | +22.97% | -9.49% | +9.45% | +11.81% | n/a |
| Other Revenue | 26.47M | 25.89M | 26.04M | 22.36M | 24.75M | 25.36M | 22.94M | 18.56M | 18M | 37.56M | 18.16M | 20.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Revenue Growth | +2.22% | -0.57% | +16.44% | -9.64% | -2.42% | +10.59% | +23.56% | +3.16% | -52.09% | +106.84% | -10.45% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue | 27.65M | 31.2M | 30.48M | 28.08M | 26.86M | 27.19M | 25.59M | 27.07M | 26.54M | 28.52M | 28.64M | 30.99M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| United States Revenue Growth | -11.39% | +2.38% | +8.54% | +4.53% | -1.21% | +6.23% | -5.46% | +2.02% | -6.97% | -0.42% | -7.56% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 25.04M | 31.85M | 28.92M | 27.31M | 26.93M | 28.11M | 29.18M | 27.18M | 27.04M | 27.68M | 24.57M | 27.4M | 30.23M | 30.04M | 25.98M | 16.33M | 16.28M | 17.68M | 17.93M | 14.4M | 14.17M | 15.38M | 15.67M | 9.98M | 9.73M | 10.98M | 9.79M | 9.3M | 9.49M | 8.64M | 8.2M | 8.7M | 9.54M | 7.41M | 8.29M | 8.67M | 8.4M | 8.11M | 7.4M | 9.07M | 6.54M | 6.48M |
| Selling, General, and Administrative Revenue Growth | -21.37% | +10.11% | +5.89% | +1.41% | -4.17% | -3.67% | +7.36% | +0.52% | -2.33% | +12.68% | -10.35% | -9.37% | +0.64% | +15.66% | +59.10% | +0.30% | -7.91% | -1.39% | +24.48% | +1.60% | -7.85% | -1.86% | +57.08% | +2.56% | -11.43% | +12.24% | +5.25% | -2.03% | +9.79% | +5.44% | -5.77% | -8.77% | +28.73% | -10.64% | -4.35% | +3.13% | +3.63% | +9.56% | -18.39% | +38.77% | +0.93% | n/a |
| Research and Development Revenue | 4.98M | 5.1M | 5.05M | 4.63M | 4.74M | 5.2M | 4.29M | 4.99M | 4.81M | 5M | 4.8M | 4.99M | 5.7M | 5.18M | 5.16M | 2.61M | 2.81M | 2.67M | 2.71M | 2.41M | 2.6M | 2.31M | 2.11M | 915K | 1.02M | 967K | 860K | 842K | 837K | 749K | 752K | 885K | 1.15M | 1.22M | 861K | 1.04M | 1.03M | 1.04M | 975K | 991K | 963K | 835K |
| Research and Development Revenue Growth | -2.20% | +0.85% | +9.04% | -2.13% | -8.98% | +21.15% | -14.00% | +3.78% | -3.86% | +4.32% | -3.85% | -12.47% | +10.06% | +0.29% | +97.63% | -7.04% | +5.16% | -1.18% | +12.05% | -7.01% | +12.33% | +9.53% | +130.60% | -10.21% | +5.38% | +12.44% | +2.14% | +0.60% | +11.75% | -0.40% | -15.03% | -23.24% | -5.18% | +41.23% | -17.61% | +0.97% | -0.77% | +6.97% | -1.61% | +2.91% | +15.33% | n/a |
| Sales and Marketing Revenue | 10.93M | 11.27M | 10.45M | 9.85M | 10.12M | 10.26M | 9.74M | 9.65M | 8.98M | 9.78M | 8.44M | 9.2M | 10.02M | 9.85M | 8.96M | 4.64M | 4.86M | 5.87M | 4.75M | 3.79M | 4.08M | 4.36M | 4.07M | 2.27M | 2.21M | 2.51M | 2.05M | 1.8M | 1.89M | 1.91M | 1.94M | 2.29M | 2.68M | 2.43M | 2.41M | 2.69M | 2.42M | 1.9M | 1.52M | 2.29M | 1.8M | 2M |
| Sales and Marketing Revenue Growth | -2.97% | +7.83% | +6.10% | -2.64% | -1.42% | +5.39% | +0.90% | +7.51% | -8.21% | +15.91% | -8.29% | -8.21% | +1.75% | +9.97% | +92.94% | -4.43% | -17.18% | +23.42% | +25.54% | -7.09% | -6.56% | +7.23% | +78.85% | +2.99% | -12.10% | +22.30% | +13.86% | -4.55% | -1.25% | -1.44% | -15.12% | -14.59% | +10.34% | +0.79% | -10.58% | +11.14% | +27.85% | +24.98% | -33.70% | +27.18% | -10.01% | n/a |